Presentation in the section „Clinical studies presented by young doctors”

THURSDAY, OCTOBER 19th

CROWNE  HALL 1

15.30-15.40 D.A. Moteli*, A. Mihăescu, L. Marc, O.C. Iancu, F. Bob, F. Gădălean, O. Schiller, B. Adela, R. Timar, S. Velciov, G. Bozdog, B. Timar, A. Schiller – Contrast-induced acute kidney injury in centres frequently using high dose contrast media investigations

CROWNE  HALL 2

14.55-15.05 L. Marc*, F. Gădălean, A Mihăescu, D Moteli, G. Bozdog,  F. Bob, S. Velciov, D. Mihăilescu, A. Mateş, O. Schiller, L. Petrică, A. Schiller – Referral to nephrologist, initiation of hemodialysis and care of advanced CKD patients in western Romania

18.10-18.20 G. Ştefan, N. Pană*, S. Stancu, C. Florescu, G. Mircescu, C. Căpuşă – Biopsy-proven glomerulopathies in elderly: Retrospective unicentric Study

FRIDAY, OCTOBER 20th  

 CROWNE  HALL 1

15.40-15.50 Ş.C Bîlha*, M.C. Ungureanu, D. Brănişteanu, A. Covic – Fibroblastic growth factor 23 beyond Chronic Kidney Disease: A novel predictor for low bone mass in women?

15.50-16.00 L. Gârneaţă, E.A. Mocanu*, A. Stancu, D. Dragomir, G. Ștefan, G. Mircescu – Ketoanalogue-supplemented vegetarian very-low protein diet in advanced chronic kidney disease: Effects on mineral and bone disorders 

 CROWNE HALL 2

10.05-10.15 B. Sorohan*, V. Berbecar, A. Andronesi, M. Paraschiv, B. Obrişcă, R. Jurubiţă, G. Ismail – Safety and efficiency of metformin in autosomal dominant polycystic kidney disease patients: A pilot study

10.35-10.45 D.C. Tirinescu*, D.Ş. Vlăduţiu, I.M. Paţiu, C.C. Rusu, D.T. Moldovan, A.R. Potra, A.L. Coman, I.M. Kacso – Ultrasound evaluation and role of neointimal hyperplasia in arteriovenous fistula patency

15.20-15.30 V. Vinereanu*, A. Niculae, I. Peride, D. Rădulescu, C. David, I.A. Checheriţă – The role of oxidative stress in arteriovenous fistula failure: A new marker for predicting vascular access patency

SATURDAY, OCTOBER 21st  

CROWNE HALL 2

10.35-10.45 L. Gârneaţă, T. Simionescu*, A. Stancu, P. Luca, I. Nicolae, G. Mircescu – Impact of hypoproteic diet supplemented with ketoanalogues on severe proteinuria in patients with diabetic kidney disease

10.45-10.55  O. Popa*, A.M. Mehedinţi, D. Dumitru, M. Lipan, G. Mircescu, C. Căpuşă – Does the treatment of asymptomatic hyperuricemia influence the clinical outcome of non-dialysis chronic kidney disease patients?

15.50-16.00 C. Căpuşă, L.I.Torsin, C. Chiriac*, D. Maria, D. Dumitru, E. Moţa, G. Mircescu – The impact of treatment with native vitamin D or selective vitamin D receptor activator on fibroblastic growth factor 23 in non-dialysis chronic kidney disease: A 6-month randomized controlled study